Últimos Artículos de Endocrine Related Cancer
- Reappraisal of BRAF K601E-positive thyroid tumors in the NIFTP era
- Genotype/phenotype correlations in multiple endocrine neoplasia type 2
- AGO2 protein: a key enzyme in the miRNA pathway as a novel biomarker in adrenocortical carcinoma
- Impact of age on genomic alterations and the tumor immune microenvironment in papillary thyroid cancer
- Exploring chromosomal instability and clonal heterogeneity in breast cancer
- Body composition in recurrent prostate cancer and the role of steroidogenic genotype
- Cutoff value of thyroglobulin in needle aspirates for screening neck masses of thyroid carcinoma
- RETRACTION: Improvement of chemotherapeutic drug efficacy by endoplasmic reticulum stress
- Cushing syndrome from an ACTH-producing pheochromocytoma or paraganglioma: structured review of 94 cases
- Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple-negative breast cancer patients
- Promoter mutation-independent TERT expression is related to the immune-enriched milieu in papillary thyroid cancer
- Nutrition, GH/IGF-1 signaling, and cancer
- MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy
- Endocrine cancer trends 1990–2021: global disparities and health inequalities
- Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center
- SDHA-related phaeochromocytoma and paraganglioma: review and clinical management
- Management of advanced high grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): comprehensive review of the current literature
- A pilot study of the immune microenvironment of GI neuroendocrine carcinoma
- Thyroid dysfunction caused by immune checkpoint inhibitors improves cancer outcomes
- Distinct transcriptional and prognostic impacts of TERT promoter mutations C228T and C250T in papillary thyroid carcinoma